RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
 Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
The Lancet Medical News Channel

subscribe to Medical News newsletter
Medical News

   EMAIL   |   PRINT
WHO's HIV Initiative Might Fail

May 8, 2005 - 7:58:00 PM
Lack of financial resources, staff, and commitment from key countries, may hamper WHO's goal to provide life-long antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005 (3 by 5), states an editorial in this week's issue of THE LANCET.

 
[RxPG] Though progress has been made with 720,000 people in developing countries receiving antiretroviral treatment and three times the target number of outlets providing antiretrovirals, the financial resources allocated to 3 by 5 are below what are needed (US$ 163 million vs 174 million), and the number of WHO staff deployed to the initiative is well below what it should be (112 vs 400). Only 30 countries have established treatment goals instead of the December target of 50. Three countries in particular need to show their commitment--India, South Africa and Nigeria. Overall it is in Africa that the greatest barrier exists, states the editorial. Of the estimated 4 million in Africa who need antiretrovirals, only 325, 000 (8%) were on treatment by December. Despite huge successes in Uganda and Botswana, for example, with both countries already delivering antiretrovirals to half their affected populations, the burden of disease remains great and the distribution of antiretrovirals is poor in South Africa, Nigeria, Zimbabwe, Tanzania, and Ethiopia.


Publication: The Lancet
On the web: www.thelancet.com 

Advertise in this space for $10 per month. Contact us today.


Related Medical News News
Gogoi announces Rs.5 lakh each to HIV victims, four officials suspended
Woman's complain against hospital dismissed
Apollo Hospital offers senior citizens only OPD
New mental health bill bans electric shocks, gives right to treatment
Caution: Eating Goan frog legs could cause cancer
Assam town protests blood bank's HIV 'mistake'
'Collaboration key to addressing problems of disabled'
Mumbai gets special cancer centre for women
Assam blood bank accused of spreading HIV virus
Re-build society with safe blood transfusion: A.K. Walia

Subscribe to Medical News Newsletter

Enter your email address:


 Additional information about the news article
The Lancet comments: "If the 3 by 5 programme had the political clout to influence South Africa alone to implement all its recommendations, where the necessary infrastructure largely exists, then the 3 million target would be more likely to be attained. Without South Africa on board, with its 837 000 people affected by HIV/AIDS and its leadership position within Africa, 3 by 5 is but a pipe dream."
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)